Traditionally, during a Mab-purification campaign a CIP cycle is recommended following every purification cycle. The CIP protocols provide a thorough removal of host cell protein (HCP) contaminants adsorbed to the resin. CIP also disengages residual aggregates so as to leave a thoroughly regenerated resin capable of binding the next batch of antibody in a purification campaign. Frequent CIP following every purification cycle, however, is not only time consuming but also cost inefficient.
MabSelect SuRe resin enables reduction of the total numbers of CIP cycles by spacing their intervals up to as far as every tenth cycle while still maintaining low production costs due to the potential to use higher NaOH solution concentrations. The DBC of the MabSelect SuRe resin for humanized IgG1 is maintained at more than 99% of its initial value following 21 purification cycles in conjunction with the optimized CIP protocol.
This optimized CIP protocol, performed following every tenth purification cycle on MabSelect SuRe resin, will reduce the overall COG due to the realization of increased number of purification cycles (Figure 3).
In this 21-cycle study all the recovered fractions of pure humanized IgG1 were 99% monomer as analyzed by size exclusion chromatography. This is in keeping with a yield of greater than 90% pure IgG1 during all 150 cycles of the earlier study. Additionally, the yield of IgG4 was greater than 93% over 100 purification cycles.
Measurement of HCP using ELISA or other methods is often used to indicate the consistency of bioprocesses. Regulatory authorities do not set global limits for the levels of residual HCPs present in final product. Dose and route of administration of the final product are among several factors that determine the acceptable levels of HCPs. However, the HCP clearance profile for MabSelect SuRe resin shows that during the 21 purification cycles, the levels of HCP per mg soluble monomer humanized IgG1 were were consistently at 1,600 ppm.
HCP in the pure IgG4 eluates from 100 purification cycles on MabSelect SuRe were screened for presence of HCP contaminants on a Western blot by probing the membrane with polyclonal antibodies raised against the HCP and against the immunoglobulin (Figure 4).
The absence of protein bands in lanes 18 and 19 indicate neither carryover nor cross-contamination in low pH-mediated eluates from cycles lacking feedstock applications performed following the 50th and 100th purification cycles respectively. The presence of bovine serum albumin and hIgG in lane 2, as the negative and positive controls, respectively, marks the specificity of the two sets of antibodies. Lane 1 shows the molecular marker proteins.
The trace amounts of ligand leakage from a protein-based affinity resin need to be removed by subsequent purification steps like multimodal chromatography, ion-exchange, or hydrophobic interaction chromatography. Protein A levels from MabSelect SuRe resin are low because of high protease stability of the genetically engineered Protein A ligand. Nonetheless, it is essential to monitor the levels of ligand in the desorbed fractions in order to stay within the acceptable limits.